Business

Bionano Announces Presentations Featuring OGM Utility Across Blood Cancer Research at the American Society of Hematology (ASH) Annual Meeting

A platform presentation will feature Dr. Enze Liu from the Indiana University School of Medicine sharing findings from a study on the use of optical genome

articleBionano Genomics, Inc.December 6, 20235/company/bionano-genomics-inc/news/bionano-announces-presentations-featuring-ogm-utility-across-blood-cancer-research-at-the-american-society-of-hematology-ash-annual-meeting
Bionano Announces Presentations Featuring OGM Utility Across Blood Cancer Research at the American Society of Hematology (ASH) Annual Meeting

About this update from Bionano Genomics, Inc.

[{"type":"text","content":"A platform presentation will feature Dr. Enze Liu from the Indiana University School of Medicine sharing findings from a study on the use of optical genome mapping (OGM) to detect structural variants (SVs) in multiple myelomaThirteen scientific posters featuring results from OGM applications in myeloid cancers, acute lymphoblastic leukemia (ALL), myelodysplastic syndromes (MDS) and hematological malignancy research will be presented at the conference SAN DIEGO, Dec. 06, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that the American Society of Hematology (ASH) Annual Meeting and Exposition 2023 will feature a broad range of content covering OGM’s utility for research in areas including myeloid cancer, hematological malignancy, leukemia and blood disorders. ASH’s Annual Meeting brings together industry, medical, and academic professionals to discuss advances in the field of blood disease. The ASH conference will be held December 9-12, 2023, in San Diego, California and online. Dr. Enze Liu from Indiana University Medical Center will present findings from a research study utilizing OGM to detect complex SVs in plasma cells that may be associated with disease progression in multiple myeloma (MM) as part of a session titled “Multiple Myeloma and Plasma Cell Dyscrasias: Basic and Translational: Molecular Characterization of MM and Precursor Disease States.” The presentation will take place Sunday, December 10, 2023, at 5:30 pm PT at the Manchester Grand Hyatt Harbor Ballroom. 13 posters featuring results from OGM applications in cytogenetic research will be presented at the conference. Unless otherwise noted below, posters will be available to view at the Manchester Grand Hyatt Harbor Ballroom. Posters displayed at the conference may also be viewed here; online only posters may be viewed here. Scientific presentations and poster sessions from Bionano and collaborators include: Poster NumberTitleAuthorPresented1414Partner Gene Associated Trinary Fusion and Orchestration of Multiple Molecular Events in Acute Promyelocytic Leukemia with Variant Rara Fusion GenesChen J.December 9, 20235:30-7:30 PM PT1610Deciphering the Structural Variants in B Cell Acute Lymphoblastic Leukemia by Optical Genome MappingLiu M.December 9, 20235:30-7:30 PM PT2834Optical Genome Mapping for Genome-Wide Structural Variation Anal...

More updates from Bionano Genomics, Inc.